In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F |
Revenues | 1.4 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Revenue growth | 650.6% | | | | | | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 1.4 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross margin | 100.0% | 100.0% | | | | | |
Selling, general and administrative [+] | 30.7 | 22.6 | 9.0 | 5.9 | 9.1 | 1.9 | 1.2 |
General and administrative | | | | 5.9 | 9.1 | | 1.2 |
Research and development | 36.9 | 41.8 | 31.3 | 51.6 | 88.9 | 10.4 | 6.3 |
Equity in earnings | | | | | | | 0.0 |
Other operating expenses | -0.4 | | | | | | |
EBITDA [+] | -65.7 | -64.1 | -40.2 | -57.5 | -97.9 | -12.4 | -7.5 |
EBITDA growth | 2.5% | 59.4% | -30.0% | -41.3% | 693.1% | 64.5% | |
EBITDA margin | -4865.7% | -35630.0% | | | | | |
Depreciation and amortization | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
EBIT [+] | -65.8 | -64.2 | -40.3 | -57.5 | -98.0 | -12.4 | -7.5 |
EBIT growth | 2.5% | 59.3% | -30.0% | -41.3% | 692.2% | 64.5% | |
EBIT margin | -4870.2% | -35672.8% | | | | | |
Non-recurring items | 0.4 | | | | | | |
Interest expense, net [+] | 0.0 | 0.0 | 0.0 | -0.2 | -0.1 | 0.0 | 0.5 |
Interest expense | 0.1 | 0.1 | 0.2 | | | | 0.5 |
Interest income | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
Other income (expense), net [+] | 1.6 | 0.4 | 0.0 | -0.1 | 1.5 | -0.2 | 0.0 |
Gain (loss) on sale of assets | | | | | | | 0.0 |
Gain (loss) on foreign currency transactions | 0.2 | 0.4 | 0.0 | -0.5 | 0.6 | -0.2 | 0.0 |
Other | 1.4 | 0.0 | | 0.3 | 0.9 | | |
Pre-tax income | -64.6 | -63.8 | -40.3 | -57.5 | -96.4 | -12.5 | -8.1 |
Income taxes | 3.6 | 0.0 | 0.0 | -2.6 | -4.6 | -0.5 | -0.1 |
Tax rate | | 0.0% | 0.0% | 4.5% | 4.8% | 4.3% | 1.0% |
Minority interest | -4.0 | -2.8 | -2.2 | -2.6 | -4.6 | -0.5 | -0.1 |
Net income | -64.2 | -61.0 | -38.1 | -54.9 | -91.8 | -12.0 | -8.0 |
Net margin | -4750.5% | -33873.9% | | | | | |
|
Basic EPS [+] | ($1.64) | ($2.03) | ($1.55) | ($2.42) | ($4.40) | ($0.75) | ($0.57) |
Growth | -19.1% | 31.6% | -36.2% | -45.0% | 489.0% | 30.3% | |
Diluted EPS [+] | ($1.64) | ($2.03) | ($1.55) | ($2.42) | ($4.40) | ($0.75) | ($0.57) |
Growth | -19.1% | 31.6% | -36.2% | -45.0% | 489.0% | 30.3% | |
|
Shares outstanding (basic) [+] | 39.0 | 30.0 | 24.6 | 22.7 | 20.9 | 16.1 | 13.9 |
Growth | 30.1% | 21.7% | 8.7% | 8.6% | 29.7% | 15.6% | |
Shares outstanding (diluted) [+] | 39.0 | 30.0 | 24.6 | 22.7 | 20.9 | 16.1 | 13.9 |
Growth | 30.1% | 21.7% | 8.7% | 8.6% | 29.7% | 15.6% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |